Navigation Links
Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem
Date:3/8/2012

BERN, Switzerland, March 8, 2012 /PRNewswire/ --

  • Quality of Life (QoL) is strongly diminished in RVVC patients
  • Current available treatment fails in two thirds of patients
  • High medical need demands novel effective treatment options

Pevion Biotech AG today announced results from a large, international survey on the Quality of Life (QoL) of recurrent vulvovaginal candidiasis (RVVC) patients. It is the first time that the overall disease burden of RVVC has been quantified by validated tools, thereby showing that QoL is strongly diminished and that RVVC has a significant impact on patients' daily activities and productivity. The survey furthermore confirmed previous findings that current use of antifungal drugs is inadequate and that it presents a therapeutic failure in more than two thirds of the RVVC patients.

"This study not only highlights the heavy burden associated with the disease, but also the very high unmet medical need," said Professor Mondher Toumi, Chair of Market Access at the University of Lyon 1, France. "The lack of effectiveness and constraint related to chronic treatment are a source of low compliance because there is low perceived benefit with current treatment. Based on cost per quality-adjusted life year (QALY) the society appears ready to pay a high price for an effective intervention in that indication."

"Pevion recently announced the outcome of the largest epidemiological survey ever performed regarding RVVC, confirming that 7% of all adult women suffer from this disease," commented Evert Kueppers, Pevion's Chief Executive Officer. "The outcome of this Quality of Life study confirms that RVVC not only is wide spread, but that it also has a significant impact on the lives of millions of women suffering from RVVC. Presently, RVVC is an under-recognized public health problem affecting mostly young and active parts of the society."

Recurrent vulvova
'/>"/>

SOURCE Pevion Biotech AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pevion Biotech Appoints New CEO and Secures CHF 10 Million Financing
2. Pevions Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study
3. Pevion Grants CSL Option Right to its Therapeutic Candida Vaccine
4. Pevions Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 You,re visiting the dentist for ... when he or she says you need a root ... you may have several questions and feel apprehensive about ... know it,s nothing to worry about. The Pennsylvania Dental ... alleviate any anxiety the public may have surrounding this ...
(Date:12/19/2014)... 2014 In today,s increasingly global marketplace ... to reflect the needs of a global marketplace ... the needs of key stakeholders while recognizing regional ... According to recent research by benchmarking firm, Best ... companies averaged more than $100,000 in annual spending ...
(Date:12/19/2014)... December 18, 2014 Radiology ... that is used to store, manipulate, and distribute ... a patient tracking and scheduling system, result reporting, ... RIS with HIS and other databases improves the ... and patient scheduling, patient list management, radiology department ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Building a Best-in-Class Pharma Global Brand Website 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3
... Dec. 22 Prasco Laboratories announced today that they have ... a GlaxoSmithKline company, for Clobetasol Propionate Foam 0.05%, the latest ... of the agreement, Prasco will market and distribute Clobetasol Propionate ... under the Prasco label. , "We are pleased to provide ...
... , , SANTA CLARA, Calif., Dec. 22 NewCardio, Inc., ... today announced that Dr. Ihor Gussak, Ph.D., F.A.C.C., NewCardio,s Vice ... of speakers, moderators and panelists at the Center for Business ... is scheduled for January 12 and 13, 2010, at the ...
Cached Medicine Technology:Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam 2Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam 3NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 2NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 3NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 4
(Date:12/19/2014)... -- All children should have their eyesight checked between ... eye experts say. The new vision-screening guidelines for ... U.S. National Center for Children,s Vision Health. The ... screening for eye problems, particularly vision issues that ... and strabismus (a disorder of eye alignment). Early ...
(Date:12/19/2014)... News) -- The cost of cancer treatment can cause ... finds. Researchers examined data from 1,000 people in ... or lung cancer. Of those patients, almost 900 had ... 100 had advanced cancer. Nearly half of the ... bills, which was linked with a poorer health-related quality ...
(Date:12/19/2014)... Dennis Thompson HealthDay Reporter ... Ebola,s entrance into the United States -- along with ... outbreak -- have highlighted cracks in the nation,s public ... health policy report released Thursday. Half of U.S. ... to infectious disease outbreaks. That was the main conclusion ...
(Date:12/19/2014)... 19, 2014 Novellus Healthcare Communications, ... Pharmacy & Clinics™, an independent journal that provides ... and caring for patients inside the pharmacy and ... to provide optimal access to quality care, Inside ... for the team treating and coordinating patient care ...
(Date:12/19/2014)... December 19, 2014 From November 24, 2014, ... training for the year 2014 in its Goa retreat ... year. Through the Indian winters, from November to March, Siddhi ... beautiful beach of Arambol, Goa. The Goa training sessions will ... intakes of yoga teacher training, the 10th intake is also ...
Breaking Medicine News(10 mins):Health News:Preschoolers Need Eye Screening, Experts Say 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 2Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 3Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3
... that not only modify diet and physical activity but ... lose weight and maintain that loss for at least ... adolescents the effect lasts for at least 12 months. ... change programs for adolescents may provide additional benefits. , ...
... 20 Exponent, Inc. (Nasdaq: EXPO ), today ... quarter and fiscal year ended January 2, 2009, immediately following ... The Company will host a corresponding conference call and ... Time. Michael Gaulke, Chairman and Chief Executive Officer, and ...
... tests, researchers say , , TUESDAY, Jan. 20 (HealthDay News) ... developing a saliva test for monitoring type 2 diabetes, ... the first time, researchers from Oregon and India have ... people with diabetes than in non-diabetics. Using these proteins, ...
... of patient,s condition, chances of recovery , , TUESDAY, Jan. 20 ... within the heart have been made by U.K. scientists using ... research shows that the amount of bleeding can indicate the ... of this kind of imaging, along with other tests, could ...
... HARRISBURG, Pa., Jan. 20 Consumers who purchased raw ... Lancaster County, should discard it immediately due to the ... today. Raw milk has not been pasteurized to kill ... must have a permit and have product samples tested ...
... Hospital & Medical Center and The Sports Medicine Clinic ... L. Smith, MD has joined the medical staff. He ... expertise in shoulder and elbow surgery.Dr. Smith received his ... School of Medicine in Springfield, IL. He completed ...
Cached Medicine News:Health News:Child and adolescent obesity: Family-based programs including behavior therapy can work 2Health News:Exponent to Announce Fourth Quarter and Fiscal Year 2008 Results 2Health News:Saliva Test Could Monitor Type 2 Diabetes 2Health News:MRI Scans Reveal Post-Heart Attack Bleeding 2Health News:Orthopaedic Surgeon Kevin Smith, MD, Joins Northwest Hospital & Medical Center and The Sports Medicine Clinic 2
... is appropriate for pre-surgical patient preparation ... spray); disinfecting of wounds and burns; ... and abrasions. It also acts as ... and office procedures, providing protection against ...
These are simple but effective single-dose, hands-off, ampulized applicators have revolutionized skin preparation in healthcare facilities....
... can be a valuable tool in standardizing ... items necessary for a procedure are supplied ... continuum of care are easier to be ... sequence of use, allowing the clinician to ...
... Triad Plus Povidone Iodine ... saturated with a 10% Povidone ... 1% available Iodine. Triad Plus ... Sticks are saturated with a ...
Medicine Products: